Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000874015-17-000063
Filing Date
2017-10-20
Accepted
2017-10-20 17:34:25
Documents
1
Period of Report
2017-10-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 13549
  Complete submission text file 0000874015-17-000063.txt   14949
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Issuer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address
PARSHALL B LYNNE (Reporting) CIK: 0001073385 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19125 | Film No.: 171147760